About CPL Biologicals Private Limited
Data last updated:
CPL Biologicals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Cadila Pharmaceuticals Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U01403GJ2009PTC056409. Its GSTIN is 24AADCC6095M1ZB (Gujarat).
The company has an authorised share capital of ₹95 Cr and a paid-up capital of ₹45.27 Cr. It was formerly known as Cpl Biologicals Limited. It is led by directors including Ramesh Ratilal Choksi and Rajiv Indravadan Modi.
Its last annual general meeting (AGM) was held on 30 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 708 Cadila Corporate Campus Sarkhej – Dholka Road Bhat, Ahmedabad, Gujarat, India – 382210.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.01 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹72.6 Lakh (net margin 9.1%) and EBITDA of ₹2.2 Cr (EBITDA margin 27.4%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 13% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: CPL Biologicals. The company has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹45.22 Cr; the latest was in April 2018. The company has 2 MSME Form 1 returns on record between 2018 and 2019, listing 21 overdue payments to 6 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cplbio.com.
Company details
CIN history
CPL Biologicals has one previous CIN (Corporate Identification Number): U01403GJ2009PLC056409. The current CIN is U01403GJ2009PTC056409, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U01403GJ2009PTC056409 | Current |
| U01403GJ2009PLC056409 | Previous |
Contact details
CPL Biologicals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is cplbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address708 Cadila Corporate Campus Sarkhej – Dholka Road Bhat, Ahmedabad, Gujarat, India – 382210
- IndustryPharma, Drug Formulation & Development
To see the full contact details of CPL Biologicals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
CPL Biologicals operates one associated brand: CPL Biologicals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops high-quality vaccines, biologics, and diagnostics using advanced biological technologies. | cplbio.com |
Business activity
The main business activity of CPL Biologicals is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of CPL Biologicals Private Limited, buy the company report.
Financials of CPL Biologicals Private Limited
FY 2025 filings availableCPL Biologicals Private Limited reported revenue of ₹8.01 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 6% fall in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.2 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹72.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.4% | ||||
| Net Profit Margin | 9.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of CPL Biologicals Private Limited, buy the company report.
Board of directors of CPL Biologicals Private Limited
CPL Biologicals has 4 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Ratilal Choksi Also directs: La Vie Biologicals Private Limited, Cadila Pharmaceuticals Limited, Gig - Irm Glass Insulators Private Limited and 5 more | Director | 03 Nov 2018 | 7 Years 11 Months | Current |
| Rajiv Indravadan Modi | Director | 24 Mar 2009 | 17 Years 7 Months | Current |
| Amitabha Banerjee | Director | 19 Dec 2024 | 1 Years 10 Months | Current |
| Rajiv Rajiv Modi Also directs: Irm Energy Limited, La Vie Biologicals Private Limited, Cadila Pharmaceuticals Limited and 5 more | Director | 04 Jul 2024 | 2 Years 3 Months | Current |
Auditor
CPL Biologicals Private Limited is audited by MUKESH M. SHAH & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUKESH M. SHAH & CO. | FY 2023 | 106625W |
Shareholding
The shareholding of CPL Biologicals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of CPL Biologicals Private Limited, buy the company report.
Deals & funding
CPL Biologicals Private Limited has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹45.22 Cr; the latest was in April 2018.
Deals on record (1 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2009 | Funding round | ₹19.95 Cr | Investors: Cadila Pharmaceuticals Limited , Novavax Inc USA |
To see the full deal history of CPL Biologicals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving CPL Biologicals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
CPL Biologicals Private Limited has 2 MSME Form 1 returns on record between 2018 and 2019, listing 21 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Teknirvana Tradelink Private Limited | |||
| an individual supplier | |||
| Labindia Instruments Pvt Ltd | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of CPL Biologicals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
CPL Biologicals Private Limited has a workforce of 24 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
GST
CPL Biologicals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCC6095M1ZB | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of CPL Biologicals Private Limited, buy the company report.
Recent activity
CPL Biologicals Private Limited has 40 board changes on record since 2009: 22 appointments and 18 cessations. The latest: Amitabha Banerjee was appointed as Director on 19 Dec 2024.
31 earlier events are in the company report.
Frequently asked questions
CPL Biologicals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 March 2009 (17+ years old) and is registered under CIN U01403GJ2009PTC056409.
CPL Biologicals has 4 current directors:
- Ramesh Ratilal Choksi - Director
- Rajiv Indravadan Modi - Director
- Amitabha Banerjee - Director
- Rajiv Rajiv Modi - Director
The latest financial statements of CPL Biologicals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of CPL Biologicals is 24AADCC6095M1ZB, registered in Gujarat.
The CIN (Corporate Identification Number) of CPL Biologicals is U01403GJ2009PTC056409. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
CPL Biologicals was incorporated on 24 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Ahmedabad.
CPL Biologicals has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹45.22 Cr; the latest was in April 2018.
Amitabha Banerjee was appointed as Director on 19 Dec 2024. Rajiv Rajiv Modi was appointed as Director on 04 Jul 2024. Niraj Vinodkumar Jain ceased to be Company Secretary on 12 Apr 2024. CPL Biologicals has 40 board changes on record in total.
CPL Biologicals has 2 MSME Form 1 returns on record between 2018 and 2019, listing 21 overdue payments to 6 micro and small suppliers. The latest return was filed on 29 May 2019.
CPL Biologicals can be reached through the website cplbio.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of CPL Biologicals is at 708 Cadila Corporate Campus Sarkhej – Dholka Road Bhat, Ahmedabad, Gujarat, India – 382210.